Crossmark

Retrospective study of Dana Farber Consortium Protocol in newly diagnosed Egyptian adolescents and young adults with acute lymphoblastic leukemia: Tanta experience

Crossref DOI link: https://doi.org/10.1186/s43046-021-00064-6

Published Online: 2021-04-07

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Elashtokhy, Hossam Eldin A.

Elgohary, Heba E.

Eldeep, Basant B.

Gaber, Sally M.

Elbedewy, Tamer A. http://orcid.org/0000-0003-4376-1873
License Information

Text and Data Mining valid from 2021-04-07

Version of Record valid from 2021-04-07
More Information

Article History

Received: 1 September 2020

Accepted: 25 February 2021

First Online: 7 April 2021

Declarations

:

: The study was approved by the research ethical committee of faculty of medicine, Tanta University. Institutional Review Board (IRB) for human studies (Approval code is 34071). Our study conforms to provisions of the Declaration of Helsinki. Informed written consent to participate in this study was provided by all participants (or their parent or legal guardian) before the starting of data collection.

: Informed written consent for publication was obtained from all participants (or their parent or legal guardian) before the starting this study.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below